Viome

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Viome sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).

18 total trials 9 currently recruiting 5 completed top decile by trial count

Viome: 18 sponsored US clinical trials, 9 recruiting.

Viome sponsors 18 registered US clinical trials on ClinicalTrials.gov, 9 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Oral Squamous Cell Carcinoma, with 2 trials.

Top-decile sponsor footprint

Viome ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

18 total, page 1 of 1

RECRUITING

Validity of Viome's Oral/throat Cancer Test

NCT06174428

RECRUITING NA

Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Disorders

NCT06502717

RECRUITING NA

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

NCT06185192

RECRUITING NA

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

NCT05564273

RECRUITING NA

Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions

NCT05465629

RECRUITING NA

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

NCT05465616

RECRUITING

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

NCT05451303

RECRUITING

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

NCT04957511

RECRUITING

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

NCT06381232

ACTIVE NOT RECRUITING NA

Viome Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions

NCT05563857

COMPLETED NA

Efficacy of VRx MyBiotics Oral Lozenges

NCT05972330

TERMINATED

Systems Biology of Gastrointestinal and Related Diseases

NCT05579444

COMPLETED

Longitudinal Analysis of the Vaginal Microbiome

NCT05383326

TERMINATED

Microbiome in Colorectal Cancer Onset and Progression

NCT05368688

COMPLETED

Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

NCT05462314

COMPLETED

Biogeography of the Oral Microbiome

NCT05672953

COMPLETED NA

Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)

NCT04905524

TERMINATED NA

Microbiome and Axial Spondyloarthritis

NCT04713995

What is open in the Viome pipeline

9 recruiting of 18 indexed (50% open); 5 completed (28%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Oral Squamous Cell Carcinoma (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Viome: open-pipeline peers nationwide

Peers matched on 18 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

Viome sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%20%40%60% Total trials Recruiting share ViomeADC Therapeutics S.A.Akros PharmaAO Clinical Investigation and Publishing DocumentationAO Innovation Translation Center1200 Pharma1ST Biotherapeutics3ive Labs60 Degrees Pharmaceuticals
Viome sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Viome sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 18 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this Viome page

18 registered trials is a research-attention snapshot, not an endorsement of Viome or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Viome pipeline card: 18 registered trials from official public datasets.Report a data error.